Atlas Trials

RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)

Clinical trial NCT03445650 · COMPLETED

Trial details

NCT number
NCT03445650
Sponsor
Aldeyra Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Sjogren-Larsson Syndrome
Start date
2018-07-18
Primary completion
2020-01-18
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.